Goldman Sachs Maintains Neutral on Cue Health, Lowers Price Target to $0.75
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Matthew Sykes maintains a Neutral rating on Cue Health (NASDAQ:HLTH) and lowers the price target from $2.75 to $0.75.
June 05, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Goldman Sachs maintains a Neutral rating on Cue Health and lowers the price target from $2.75 to $0.75.
The lowered price target by Goldman Sachs analyst Matthew Sykes indicates a bearish outlook on Cue Health's stock in the short term. This news may negatively impact the stock price as investors adjust their expectations based on the new price target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100